Biosafe Laboratories, Inc.

Biosafe Laboratories, Inc. — FDA 510(k) Submissions

Biosafe Laboratories, Inc. has submitted 6 FDA 510(k) premarket notifications since 1999, of which 6 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Radioimmunoassay, Thyroid-stimulating Hormone, Assay, Glycosylated Hemoglobin, Enzymatic Esterase--oxidase, Cholesterol, Tubes, Vials, Systems, Serum Separators, Blood Collection, Whole Blood Hemoglobin Determination . Use the specialty filter in the sidebar to narrow results.